Ashley Hall
2021
In 2021, Ashley Hall earned a total compensation of $2.9M as Former Chief Development Officer at Esperion Therapeutics, a 25% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,134,130 |
|---|---|
| Salary | $270,063 |
| Stock Awards | $650,468 |
| Other | $822,588 |
| Total | $2,877,249 |
Hall received $1.1M in option awards, accounting for 39% of the total pay in 2021.
Hall also received $270.1K in salary, $650.5K in stock awards and $822.6K in other compensation.
Rankings
In 2021, Ashley Hall's compensation ranked 4,596th out of 12,415 executives tracked by ExecPay. In other words, Hall earned more than 63.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,596 out of 12,415 | 63rd |
Division Manufacturing | 1,905 out of 5,508 | 65th |
Major group Chemicals And Allied Products | 796 out of 2,378 | 67th |
Industry group Drugs | 710 out of 2,099 | 66th |
Industry Pharmaceutical Preparations | 505 out of 1,549 | 67th |
Pay ratio
| Ashley Hall's Pay | $2,877,249 |
|---|---|
| Median Employee's Pay | $217,116 |
| Pay Ratio | 13to 1 |
In 2021, the annual total compensation of Ashley Hall was $2,877,249.
The annual total compensation of the median employee at Esperion Therapeutics was $217,116.
The ratio of Ashley Hall's pay to the pay of median employee was therefore 13 to one.
Source: SEC filing on April 14, 2022.
Hall's colleagues
We found four more compensation records of executives who worked with Ashley Hall at Esperion Therapeutics in 2021.